Test Price
2,500 AEDโ Home Collection Available
Chromosomal Microarray Optima Prenatal Test in Dubai, UAE โ 2500 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing for genome-wide copy number variant detection.
- Premium Logistics: Hospital extraction only โ sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic post-test result interpretation by a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Chromosomal Microarray Optima Prenatal Test detects submicroscopic chromosomal imbalances in the fetus using genome-wide, high-resolution copy number analysis. This assay identifies deletions and duplications larger than 400 kilobases across the entire genome, offering superior resolution compared with conventional G-banded karyotyping.
| Feature | Optima CMA | Standard Karyotype |
|---|---|---|
| Precision | Detects >400 kb deletions/duplications genome-wide | Limited to >5โ10 Mb visible under light microscopy |
| Method | Affymetrix CytoScan Optima Suite (CMA) | G-banded chromosome analysis |
| Turnaround | 10 working days | 14โ21 calendar days |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Geneticist, I emphasise that chromosomal microarray results must be correlated with detailed ultrasonographic findings, maternal serum biomarkers, and comprehensive family history. No single test replaces holistic prenatal care; any abnormal finding requires prompt discussion with your obstetrician and a clinical geneticist for tailored counselling." โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory Notice
Medication Continuation
Do not stop any prescribed medication without explicit instruction from your treating physician. This prenatal diagnostic test does not replace routine antenatal monitoring or urgent medical evaluation.
Exclusion Criteria & Emergency Red Flags
- Invasive sample collection (amniocentesis or chorionic villus sampling) must be performed exclusively by a qualified obstetrician under continuous ultrasound guidance.
- Specimens with visible blood clots, inadequate volume, or transported without temperature-controlled cold chain will be rejected.
- Emergency Red Flags: Vaginal bleeding, amniotic fluid leakage, severe abdominal pain, or fever after the procedure require immediate emergency care โ do not wait for test results.
- This test is not indicated for low-risk singleton pregnancies as a first-tier screen; consult your obstetrician for appropriateness based on current DHA clinical practice guidelines.
Patient FAQ & Clinical Guidance
1. What is the turnaround time for the Chromosomal Microarray Optima Prenatal Test?
Your final report is typically ready within 10 working days after sample receipt at our ISO 9001:2015 certified laboratory. Urgent clinical requests can be expedited by contacting your referring physician or our genetic counselling team.
2. Is this test suitable for all pregnant women?
This test is specifically indicated for pregnancies with abnormal ultrasound findings, advanced maternal age, or a family history of known genetic disorders. Your obstetrician will determine medical necessity based on established DHA clinical practice guidelines and your individual risk profile.
3. How is the sample collected and what documentation is required?
A sterile sample of amniotic fluid, chorionic villus, or cord blood is collected by your obstetrician under strict aseptic conditions. Mandatory paperwork includes a completed Genomic Microarray Requisition Form (Form 19) and a signed Patient Consent Form (Form 18). Hospital extraction only โ mobile home phlebotomy is not available for this invasive procedure.
UAE Regulatory & Data Privacy Adherence
UAE Healthcare Compliance: This laboratory service operates in full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. Testing is performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) at a DHA-licensed facility. Hospital-based collection is restricted to accredited hospital settings; no home phlebotomy services are available for this invasive specimen type.
Clinical & Logistical Metadata
| Test Name | Chromosomal Microarray Optima Prenatal |
| Price (AED) | 2,500 |
| Turnaround Time | 10 working days |
| Sample Type / Matrix | Amniotic fluid, chorionic villus, cord blood โ Hospital Extraction Only (mobile home phlebotomy disabled) |
| Methodology Used | Affymetrix CytoScan Optima Suite (Chromosomal Microarray Analysis) |
| ICD-10-CM Code | Z36.8, O28.9 |
| LOINC Code | 93719-0 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians